
December 13, 2025
The FDA conducted a bioresearch monitoring inspection at Charles River Campus IRB, Boston University in Boston on August 21, 2024.
Read more →
December 12, 2025
New England Tortilla, Inc. in Boston underwent an FDA inspection on February 21, 2024, focusing on foodborne biological hazards, according to information available on the FDA's website.
Read more →
December 11, 2025
On November 27, 2024, the Food and Drug Administration conducted an inspection of DO & Company Boston, Inc. in Boston, focusing on foodborne biological hazards and providing technical assistance related to food and cosmetics, according to information available on the FDA's website.
Read more →
December 10, 2025
On July 25, 2024, the Food and Drug Administration conducted an inspection at Flynn Cruiseport Boston @ Black Falcon Terminal in Boston focusing on food and cosmetics technical assistance, according to FDA website data.
Read more →
December 9, 2025
On July 10, 2024, the Food and Drug Administration conducted an inspection of The Children's Hospital Corporation in Boston focusing on blood and blood products, according to information available on the FDA's website.
Read more →
December 8, 2025
The Commonwealth of Massachusetts Department of Mental Health CRRC in Boston underwent an FDA inspection for bioresearch monitoring on August 28, 2024, according to information available on the FDA's website.
Read more →
December 7, 2025
The FDA conducted an inspection at ABC Food, Corp. in Boston on December 20, 2024, focusing on food composition, standards, labeling, economic factors, and foodborne biological hazards.
Read more →
December 6, 2025
The FDA conducted a bioresearch monitoring inspection at Vertex Pharmaceuticals Incorporated in Boston on August 1, 2024.
Read more →
December 5, 2025
On November 7, 2024, the Food and Drug Administration conducted a bioresearch monitoring inspection at Alexion Pharmaceuticals, Inc. in Boston, as per information available on the FDA's website.
Read more →
December 4, 2025
On June 12, 2024, the Food and Drug Administration (FDA) conducted an inspection of Brigham and Women's Hospital in Boston focused on human cellular, tissue, and gene therapies, according to information available on the FDA's website.
Read more →
Sign-up for the Weekly Newsletter from Bean Town Times.